This page is part of the FHIR Specification (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Patient, Practitioner |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.
Generated Narrative with Details
id: meddisp0317
contained:
status: stopped
medication: Brentixumab Vedotin (Adcetris). Generated Summary: id: med0306; Adcetris (Brentuximab Vedotin 50mg/10.5ml) (Details : {http://hl7.org/fhir/sid/ndc code '51144-050-01' = '51144-050-01', given as 'Adcetris (Brentuximab Vedotin 50mg/10.5ml)'}); Lyophilized powder for injectable solution (qualifier value) (Details : {SNOMED CT code '421637006' = 'Lyophilised powder for injectable solution', given as 'Lyophilized powder for injectable solution (qualifier value) '})
subject: Donald Duck
- | Actor |
* | Practitioner/f006 |
authorizingPrescription: MedicationRequest/medrx0316
type: Trial Fill (Details : {http://terminology.hl7.org/CodeSystem/v3-ActCode code 'TF' = 'Trial Fill', given as 'Trial Fill'})
quantity: 3 415818005 (Details: SNOMED CT code 415818005 = '415818005')
daysSupply: 1 Day (Details: UCUM code d = 'd')
whenPrepared: 25/06/2015 7:13:00 AM
whenHandedOver: 26/06/2015 7:13:00 AM
dosageInstruction:
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.